the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Name: the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19
Published: 2020
License: Public Domain

Shahid Beheshti University of Medical Sciences · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

antiviralagents beta covid19 infectiveagents interferon interferons

covid19, covid-19, interferons, ritonavir, lopinavir, interferon-beta, antiviral agents, anti-infective agents, immunologic factors, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Related documents